616 related articles for article (PubMed ID: 12385436)
61. Inadequate prevention of NSAID-induced gastrointestinal events.
Herings RM; Goettsch WG
Ann Pharmacother; 2004 May; 38(5):760-3. PubMed ID: 15031416
[TBL] [Abstract][Full Text] [Related]
62. [Peptic ulcer in Denmark, 1981-1993. Analysis of data from national patient registries].
Andersen IB; Bonnevie O; Jørgensen T; Sørensen TI
Ugeskr Laeger; 1999 Mar; 161(11):1589-94. PubMed ID: 10202442
[TBL] [Abstract][Full Text] [Related]
63. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study.
Ong TZ; Hawkey CJ; Ho KY
J Clin Gastroenterol; 2006 Oct; 40(9):795-800. PubMed ID: 17016134
[TBL] [Abstract][Full Text] [Related]
64. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants.
Lanas A; García-Rodríguez LA; Arroyo MT; Bujanda L; Gomollón F; Forné M; Aleman S; Nicolas D; Feu F; González-Pérez A; Borda A; Castro M; Poveda MJ; Arenas J;
Am J Gastroenterol; 2007 Mar; 102(3):507-15. PubMed ID: 17338735
[TBL] [Abstract][Full Text] [Related]
65. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.
Patterson MK; Castellsague J; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):982-8. PubMed ID: 18711705
[TBL] [Abstract][Full Text] [Related]
66. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
Rahme E; Nedjar H
Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138
[TBL] [Abstract][Full Text] [Related]
67. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
68. Adverse gastrointestinal effects of NSAIDs: consequences and costs.
Bidaut-Russell M; Gabriel SE
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):739-53. PubMed ID: 11566038
[TBL] [Abstract][Full Text] [Related]
69. The American College of Gastroenterology Bleeding Registry: preliminary findings.
Peura DA; Lanza FL; Gostout CJ; Foutch PG
Am J Gastroenterol; 1997 Jun; 92(6):924-8. PubMed ID: 9177503
[TBL] [Abstract][Full Text] [Related]
70. Selective outpatient management of upper gastrointestinal bleeding in the elderly.
Cebollero-Santamaria F; Smith J; Gioe S; Van Frank T; Mc Call R; Airhart J; Perrillo R
Am J Gastroenterol; 1999 May; 94(5):1242-7. PubMed ID: 10235201
[TBL] [Abstract][Full Text] [Related]
71. Association of nonsteroidal antiinflammatory drugs with upper gastrointestinal disease: epidemiologic and economic considerations.
Hochberg MC
J Rheumatol Suppl; 1992 Nov; 36():63-7. PubMed ID: 1474537
[TBL] [Abstract][Full Text] [Related]
72. Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee.
McManus P; Primrose JG; Henry DA; Birkett DJ; Lindner J; Day RO
Med J Aust; 1996 May; 164(10):589-92. PubMed ID: 8637461
[TBL] [Abstract][Full Text] [Related]
73. [Diagnostic imaging of NSAID ulcers].
Ono S; Kato M; Asaka M; Ono Y; Yokoyama A
Nihon Rinsho; 2007 Oct; 65(10):1792-800. PubMed ID: 17926526
[TBL] [Abstract][Full Text] [Related]
74. [Prophylaxis and treatment of NSAID-related peptic ulceration: present status and prospects].
Hiraishi H; Akima T; Sugaya T; Nakano M; Nomura M
Nihon Rinsho; 2011 Jun; 69(6):988-94. PubMed ID: 21688617
[TBL] [Abstract][Full Text] [Related]
75. Nonvariceal upper gastrointestinal bleeding.
Rollhauser C; Fleischer DE
Endoscopy; 2002 Feb; 34(2):111-8. PubMed ID: 11822006
[TBL] [Abstract][Full Text] [Related]
76. Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?
Langman MJ
Pharmacoepidemiol Drug Saf; 2001; 10(1):13-9. PubMed ID: 11417061
[TBL] [Abstract][Full Text] [Related]
77. Epidemiology and role of nonsteroidal antiinflammatory drugs in causing gastrointestinal bleeding.
Lee I; Cryer B
Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):597-612. PubMed ID: 21944413
[TBL] [Abstract][Full Text] [Related]
78. A case study: nonsteroidal antiinflammatory drugs and gastrointestinal bleeding.
Carson JL
J Rheumatol Suppl; 1988 Oct; 17():24-7. PubMed ID: 3264583
[TBL] [Abstract][Full Text] [Related]
79. [Low-dose aspirin (LDA)/nonsteroidal anti-inflammatory drugs(NSAIDs)-induced gastrointestinal injury in Japan].
Sugano K
Nihon Rinsho; 2011 Jun; 69(6):977-81. PubMed ID: 21688615
[TBL] [Abstract][Full Text] [Related]
80. Non-steroidal anti-inflammatory drugs (NSAIDs) cause gastrointestinal intolerance and major bleeding--or do they?
Tenenbaum J
Clin Invest Med; 1987 May; 10(3):246-50. PubMed ID: 3304753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
